GATEWAY PRIMARY CARE — All Prescriptions & Medications — Page 3
Practice Code: C87622 | ROTHERHAM, S65 1DA
Showing results 101-150 of 549
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mometasone furoate | 445 | 451 | £3.5K | +10.8% ▲ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 444 | 451 | £6.3K | +291.5% ▲ |
| Nitrofurantoin | 433 | 8,441 | £6.4K | -9.3% ▼ |
| Memantine hydrochloride | 430 | 12.7K | £3.4K | +30.2% ▲ |
| Warfarin sodium | 424 | 22.4K | £761 | -10.1% ▼ |
| Latanoprost | 420 | 9,160 | £2.8K | -13.5% ▼ |
| Risperidone | 415 | 18.1K | £2.2K | +64.0% ▲ |
| Tolterodine | 414 | 17.2K | £2.8K | +178.5% ▲ |
| Ezetimibe | 412 | 11.5K | £2.0K | -42.1% ▼ |
| 402 | 848 | £27.4K | -26.2% ▼ | |
| 399 | 198.6K | £1.3K | +337.6% ▲ | |
| Etoricoxib | 398 | 9,853 | £2.6K | +394.0% ▲ |
| Famotidine | 397 | 14.0K | £8.0K | -18.6% ▼ |
| Levetiracetam | 395 | 58.2K | £3.4K | -13.7% ▼ |
| Baclofen | 393 | 53.8K | £892 | +96.2% ▲ |
| Quetiapine | 387 | 12.5K | £5.0K | -37.8% ▼ |
| Hepatitis B | 377 | 377 | £4.5K | +3,462.4% ▲ |
| Bendroflumethiazide | 371 | 10.6K | £172 | -52.0% ▼ |
| Oxycodone hydrochloride | 368 | 56.5K | £6.3K | +43.8% ▲ |
| Mebeverine hydrochloride | 353 | 32.9K | £3.6K | +13.7% ▲ |
| Felodipine | 353 | 10.3K | £1.7K | -40.6% ▼ |
| Estradiol with progestogen | 353 | 14.2K | £7.2K | +3.6% ▲ |
| 352 | 112.1K | £2.4K | +33.4% ▲ | |
| Pravastatin sodium | 349 | 10.5K | £479 | +7.5% ▲ |
| Insulin aspart | 349 | 2,153 | £14.6K | -8.3% ▼ |
| Clarithromycin | 346 | 10.5K | £1.7K | +41.0% ▲ |
| Semaglutide | 341 | 1,455 | £26.1K | +41.6% ▲ |
| Budesonide | 335 | 351 | £8.7K | -38.2% ▼ |
| Umeclidinium bromide | 333 | 333 | £8.7K | +440.2% ▲ |
| Finasteride | 326 | 8,227 | £294 | -50.2% ▼ |
| Sitagliptin | 319 | 9,492 | £651 | -18.2% ▼ |
| 315 | 328 | £2.0K | +33.4% ▲ | |
| Loratadine | 312 | 10.9K | £241 | +49.3% ▲ |
| Escitalopram | 312 | 8,526 | £499 | +9.6% ▲ |
| Fluticasone propionate (Inhalation) | 309 | 312 | £6.8K | -20.1% ▼ |
| Esomeprazole | 304 | 10.7K | £1.3K | -24.9% ▼ |
| Lactulose | 304 | 149.2K | £1.4K | -7.7% ▼ |
| Glyceryl trinitrate | 302 | 1,490 | £929 | +27.7% ▲ |
| Rosuvastatin calcium | 302 | 8,582 | £446 | -66.4% ▼ |
| Donepezil hydrochloride | 302 | 8,438 | £1.9K | -2.1% ▼ |
| Calcipotriol | 296 | 22.1K | £12.9K | +73.9% ▲ |
| Quinine sulfate | 289 | 7,422 | £1.3K | -0.2% vs avg |
| Mirabegron | 289 | 8,564 | £7.9K | -28.1% ▼ |
| Methotrexate | 286 | 7,866 | £501 | -12.1% ▼ |
| Aripiprazole | 285 | 15.2K | £4.6K | +12.0% ▲ |
| Loperamide hydrochloride | 279 | 19.1K | £442 | +19.8% ▲ |
| Rivaroxaban | 278 | 9,158 | £5.0K | -54.6% ▼ |
| Cyclizine hydrochloride | 274 | 15.9K | £556 | +69.9% ▲ |
| Topiramate | 273 | 19.0K | £5.9K | +53.6% ▲ |
| Clobetasone butyrate | 273 | 11.4K | £2.7K | +33.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.